Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study
NCT00464243 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 604
Last updated 2017-08-08
Summary
The purpose of this study is to assess efficacy and safety of volinanserin in the population of patients complaining of sleep maintenance insomnia. The patients suffering from that condition frequently wake up during the night, their sleep is non restorative and they suffer from a significant distress or impairment in their daily activities consecutive to insomnia.
Conditions
- Sleep Initiation and Maintenance Disorders
Interventions
- DRUG
-
volinanserin
oral administration
- DRUG
-
oral administration
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ICD CSD · Sanofi
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2008-01-31
- Completion
- 2008-01-31
Countries
- United States
- Australia
- Austria
- Canada
- France
- Germany
- Russia
Study Locations
More Related Trials
-
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia
NCT00308503 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
NCT00805350 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity
NCT02464046 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties
NCT00679900 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
NCT00784875 ·Status: COMPLETED ·Phase: PHASE2
-
Eschscholzia Study
NCT06795776 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
NCT03375203 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
NCT01995838 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia
NCT00913614 ·Status: COMPLETED ·Phase: PHASE1
-
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
NCT00608985 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of LY2422347 to Treat Insomnia
NCT00259311 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
NCT00401284 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia
NCT00435279 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
NCT02839200 ·Status: COMPLETED ·Phase: PHASE2
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of EVT 201 to Treat Insomnia
NCT00380003 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
NCT00397189 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)
NCT02750306 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00426816 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006
NCT01463098 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)
NCT00770692 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
NCT03575104 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
NCT00569972 ·Status: COMPLETED ·Phase: PHASE2